Immucell (ICCC) Return on Invested Capital (2011 - 2026)

Immucell (ICCC) has 15 years of Return on Invested Capital data on file, last reported at 0.0% in Q4 2025.

• Quarterly Return on Invested Capital rose 1.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, up 2.0% from the prior year.
• Return on Invested Capital declined to 0.0% in Q4 2025, from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2025 to a low of 0.01% in Q3 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2021 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2021 — Return on Invested Capital gained 1 bps — and 2023, when it fell 2 bps.
• Tracing ICCC's Return on Invested Capital over 5 years: stood at 0.0% in 2021, then tumbled by 727 bps to 0.01% in 2022, then plunged by 74 bps to 0.01% in 2023, then soared by 72 bps to 0.0% in 2024, then surged by 195 bps to 0.0% in 2025.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.